Actinium Pharmaceuticals, Inc.
ATNM
Revenue
0.00
▼-45.00k▼-100.00%
3 Months ChangeAssets
76.90M
▼-5.22M▼-6.35%
3 Months ChangeLiabilities
44.14M
▲235.00k▲0.5352%
3 Months ChangeFree Cash Flow
-7.39M
▲7.77M▲51.26%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-05
Form 10-Q
ID: 0001213900-24-065239
2024-08-05
Form 8-K
ID: 0001213900-24-064993
2024-04-26
Form 10-Q
ID: 0001213900-24-036699
2023-12-01
Form 8-K
ID: 0001213900-23-092089
2023-11-02
Form 10-Q
ID: 0001213900-23-082459
2023-08-14
Form 10-Q
ID: 0001213900-23-067199
2023-05-15
Form 10-Q
ID: 0001213900-23-039902
2023-03-10
Form 8-K
ID: 0001213900-23-019289
2023-02-21
Form 8-K
ID: 0001213900-23-013059
2022-12-30
Form 8-K
ID: 0001213900-22-084094